Detalles de la búsqueda
1.
Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinoma.
Invest New Drugs
; 41(1): 115-121, 2023 02.
Artículo
Inglés
| MEDLINE | ID: mdl-36633784
2.
First-line osimertinib for poor performance status patients with EGFR mutation-positive non-small cell lung cancer: A prospective observational study.
Invest New Drugs
; 40(2): 430-437, 2022 04.
Artículo
Inglés
| MEDLINE | ID: mdl-34807331
3.
Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancer.
Invest New Drugs
; 38(6): 1906-1914, 2020 12.
Artículo
Inglés
| MEDLINE | ID: mdl-32415486
4.
Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors.
Invest New Drugs
; 38(3): 885-893, 2020 06.
Artículo
Inglés
| MEDLINE | ID: mdl-32157598
5.
Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia.
BMC Cancer
; 19(1): 163, 2019 Feb 20.
Artículo
Inglés
| MEDLINE | ID: mdl-30808322
6.
Smoking History as a Predictor of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer Harboring EGFR Mutations.
Oncology
; 95(2): 109-115, 2018.
Artículo
Inglés
| MEDLINE | ID: mdl-29698957
7.
Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer.
Invest New Drugs
; 35(5): 642-648, 2017 10.
Artículo
Inglés
| MEDLINE | ID: mdl-28631097
8.
Smoking History as a Predictor of Pemetrexed Monotherapy in Patients with Non-Squamous Non-Small Cell Lung Cancer.
Oncology
; 91(1): 41-7, 2016.
Artículo
Inglés
| MEDLINE | ID: mdl-27234033
9.
Prognostic significance of galectin-3 expression in patients with resected NSCLC treated with platinum-based adjuvant chemotherapy.
Thorac Cancer
; 12(10): 1570-1578, 2021 05.
Artículo
Inglés
| MEDLINE | ID: mdl-33793071
10.
A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Cancer Manag Res
; 13: 8695-8705, 2021.
Artículo
Inglés
| MEDLINE | ID: mdl-34849025
11.
Prognostic significance of NAP1L1 expression in patients with early lung adenocarcinoma.
Biomed Res
; 41(3): 149-159, 2020.
Artículo
Inglés
| MEDLINE | ID: mdl-32522932
12.
TRAP1 is a predictive biomarker of platinum-based adjuvant chemotherapy benefits in patients with resected lung adenocarcinoma.
Biomed Res
; 41(1): 53-65, 2020.
Artículo
Inglés
| MEDLINE | ID: mdl-32092740
13.
Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer prior to the approval of durvalumab.
Thorac Cancer
; 11(4): 1005-1014, 2020 04.
Artículo
Inglés
| MEDLINE | ID: mdl-32057187
14.
Prognostic significance of IMMT expression in surgically-resected lung adenocarcinoma.
Thorac Cancer
; 10(11): 2142-2151, 2019 11.
Artículo
Inglés
| MEDLINE | ID: mdl-31583841
15.
Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer.
PLoS One
; 14(4): e0214599, 2019.
Artículo
Inglés
| MEDLINE | ID: mdl-31002722
16.
Evaluation of osimertinib efficacy according to body surface area and body mass index in patients with non-small cell lung cancer harboring an EGFR mutation: A prospective observational study.
Thorac Cancer
; 10(4): 880-889, 2019 04.
Artículo
Inglés
| MEDLINE | ID: mdl-30821083
17.
Impact of EGFR genotype on the efficacy of osimertinib in EGFR tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study.
Cancer Manag Res
; 11: 4883-4892, 2019.
Artículo
Inglés
| MEDLINE | ID: mdl-31213907
18.
Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer.
Cancer Manag Res
; 10: 6039-6047, 2018.
Artículo
Inglés
| MEDLINE | ID: mdl-30538553
19.
Intracranial Response to Nivolumab in a Patient with PD-L1-negative Lung Adenocarcinoma.
Intern Med
; 57(21): 3149-3152, 2018 Nov 01.
Artículo
Inglés
| MEDLINE | ID: mdl-29877291
20.
Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung disease.
Cancer Manag Res
; 10: 7013-7019, 2018.
Artículo
Inglés
| MEDLINE | ID: mdl-30588105